نتایج جستجو برای: lipomembranous panniculitis

تعداد نتایج: 1254  

Journal: :Advances in therapy 2014
Carmen Márquez-Rebollo Luisa Vergara-Carrasco Rosa Díaz-Navarro Delia Rubio-Fernández Pablo Francoli-Martínez Rainel Sánchez-De la Rosa

INTRODUCTION Use of endermology (Endermologie®), which consists of a deep mechanical massage, in patients with multiple sclerosis receiving glatiramer acetate suggested improvements in injection-site indurations and panniculitis/lipoatrophy in our previous pilot experience. We aimed to assess the effect of endermology in a larger population of patients with multiple sclerosis receiving glatiram...

Journal: :Acta dermatovenerologica Croatica : ADC 2004
Nina Troskot Liborija Lugović Mirna Situm Majda Vucić

Subcutaneous panniculitis-like T-cell lymphoma is a rare form of non-Hodgkin lymphoma. It presents clinically as panniculitis, with erythematous, firm subcutaneous infiltrates and recurrent papulonodules. A 45-year-old male Croat presented with a 6-month history of tender erythematous subcutaneous skin lesions without systemic symptoms. Analysis of a lesion biopsy specimen showed circumscribed ...

Journal: :Cutis 2015
Casey E Watkins John Litchfield George Youngberg Stuart S Leicht Guha Krishnaswamy

Glatiramer acetate (GA) is a drug that commonly is used for the treatment of relapsing-remitting multiple sclerosis (RRMS). Although it typically is known as a safe and effective therapy, a number of adverse effects associated with GA have been reported in the literature. Local injection-site reactions (LISRs) and mild systemic symptoms are among the most commonly described adverse effects. A r...

2014
Claudia Pasqualini Mauro Jorini Ines Carloni Mirella Giangiacomi Valentina Cetica Maurizio Aricò, Fernando Maria de Benedictis

Cytophagic histiocytic panniculitis is a rare disease, associated with either nonmalignant conditions or subcutaneous panniculitis-like T-cell lymphoma, and often also associated with hemophagocytic lymphohistiocytosis (HLH). We report the case of a 11-year-old boy with a history of secondary HLH who, after a local trauma, developed a painful, indurated plaque over the right thigh associated wi...

Journal: :Acta dermato-venereologica 2003
Monica Corazza Raffaella Salmi Renata Strumia

Sir, Pancreatic panniculitis (PP) is a rare disease that is caused by the massive release of pancreatic enzymes into the bloodstream and results in cytosteatonecrosis of the hypodermis. PP is clinically characterized by painful or asymptomatic nodules of the legs that closely resemble erythema nodosum or infectious panniculitis (1). The nodules may sometimes spontaneously ulcerate and drain bro...

2011
Nabeel Najem Amr Sarhan

Cytophagic histiocytic panniculitis (CHP) was first described in 1980. It classically presents with intermittent recurrent episodes of pyrexia subcutaneous nodules, pancytopenia and liver dysfunction, but most patients have in addition a multitude of other manifestations which confuse the clinical picture. Despite the variable clinical course, the disease is often fatal. Diagnosis is based on h...

Journal: :The Journal of dermatology 2008
Sang Tae Kim Tae Kwon Kim Jin Woo Lee Hyo Jin Roh Soo Young Choi Young Seung Jeon Kee Suck Suh

Post-steroid panniculitis is known to be very rare and most of the reported cases have been in children after corticosteroid therapy. We present a case of post-steroid panniculitis occurring in a 60-year-old man after massive, long-term administration of corticosteroids for acute exacerbation of chronic obstructive pulmonary disease (COPD). Histopathological examination of a nodule revealed a p...

2016
Nadia Ben Abdelhafidh Sana Toujeni Asma Kefi Najeh Bousetta Sameh Sayhi Imen Gharsallah Salah Othmani

Panniculitis is an inflammatory disease of subcutaneous adipose tissue which is rarely associated with dermatomyositis. It can occur before, after or simultaneously with muscle damage. In most cases, the evolution of panniculitis and of other dermatomyositis affections is favorable with corticosteroids and/or immunosuppressants. We report the case of a 48 year-old patient who developed pannicul...

Journal: :JAMA oncology 2015
Stephanie K Fabbro Sabrina M Smith Jason A Dubovsky Alejandro A Gru Jeffrey A Jones

Panniculitis in Patients Undergoing Treatment With the Bruton Tyrosine Kinase Inhibitor Ibrutinib for Lymphoid Leukemias Ibrutinib is an oral inhibitor of Bruton tyrosine kinase (BTK) withmarked activity in several B-cell malignant neoplasms.1 Commonly reported adverse events include diarrhea, infection, fatigue, arthralgias, pyrexia, hypertension, and neutropenia.2 Grade 1 and 2 rashes have be...

2015
Agata Bednarek Leszek Bartoszak Włodzimierz Samborski

Lupus panniculitis is a rare variant of lupus erythematosus. It may occur as a separate disease or coexist with systemic or discoid lupus erythematosus. It is characterized by persistent, tender and hard nodules localised on the face, arms, shoulders, breast and buttocks. Healing of lesions is associated with scarring, lipoatrophy and rarely ulceration. Treatment of lupus panniculitis depends o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید